Epidermal growth factor inhibition of c-Myc-mediated apoptosis through Akt and Erk involves Bcl-xL upregulation in mammary epithelial cells

Experimental Cell Research

Volumn 287, Issue 2, 2003, Pages 397-410

  Ramljak, Danica ^a,d   Coticchia, Christine M ^a   Nishanian, Tagvor G ^a   Saji, Motoyasu ^b   Ringel, Matthew D ^b   Conzen, Suzanne D ^c   Dickson, Robert B ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Akt; Bcl xL; C Myc; Epidermal growth factor receptor; Erk

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; APOPTOSIS INHIBITOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL XL; PROTEIN KINASE B; 1,3 BUTADIENE DERIVATIVE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; 4 ((3 BROMOPHENYL)AMINO) 6,7 DIMETHOXYQUINAZOLINE; 4-((3-BROMOPHENYL)AMINO)-6,7-DIMETHOXYQUINAZOLINE; BCL2L1 PROTEIN, MOUSE; CHROMONE DERIVATIVE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MORPHOLINE DERIVATIVE; NITRILE; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN SERINE THREONINE KINASE; QUINAZOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST EPITHELIUM; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR BLOCKING; SURVIVAL; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; EPITHELIUM CELL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

MOUSE MAMMARY TUMOR VIRUS; MURINAE; MUS MUSCULUS;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BUTADIENES; CELL LINE; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOLINES; NITRILES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MYC; QUINAZOLINES; UP-REGULATION;

EID: 0042704792     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00135-6     Document Type: Article

References (46)

1. Nass S.J., Dickson R.B. Defining a role for c-Myc in breast tumorigenesis. Breast Cancer Res. Treat. 44:1997;1-22.
2. Liao D.J., Dickson R.B. c-Myc in breast cancer. Endocr. Relat. Cancer. 7:2000;143-164.
3. Amundadottir L.T., Nass S.J., Berchem G.J., Johnson M.D., Dickson R.B. Cooperation of TGF alpha and c-Myc in mouse mammary tumorigenesis coordinated stimulation of growth and suppression of apoptosis. Oncogene. 13:1996;757-765.
4. L in the regulation of apoptosis by EGF and TGFβ in c-myc overexpressing mammary epithelial cells. Biochem. Biophys. Res. Commun. 227:1996;248-256.
5. Roberts R.A., James N.H., Cosulich S.C. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology. 31:2000;420-427.
6. Sibilia M., Fleischmann A., Behrens A., Stingl L., Carroll J., Watt F.M., Schlessinger J., Wagner E.F.The E.G.F.receptor provides an essential survival signal for S.O.S.-dependent skin tumor development. Cell. 102:2000;211-220.
7. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell Biol. 10:1998;262-267.
8. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp. Cell Res. 253:1999;210-229.
9. Datta S.R., Brunet A., Greenberg M.E. Cellular survival a play in three Akts. Genes Dev. 13:1999;2905-2927.
10. Coffer P.J., Jin J., Woodgett J.R. Protein kinase B (c-Akt) a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335:1998;1-13.
11. Okano J., Gaslightwala I., Birnbaum M.J., Rustgi A.K., Nakagawa H. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation. J. Biol. Chem. 275:2000;30934-33094.
12. Datta S.R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 91:1997;231-241.
13. Cardone M.H., Roy N., Stennicke H.R., Salvesen G.S., Franke T.F., Stanbridge E., Frisch S., Reed J.C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 282:1998;1318-1321.
14. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 96:1999;857-868.
15. Jones R.G., Parsons M., Bonnard M., Chan V.S., Yeh W.C., Woodgett J.R., Ohashi P.S. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J. Exp. Med. 191:2000;1721-1734.
16. Pugazhenthi S., Nesterova A., Sable C., Heidenreich K.A., Boxer L.M., Heasley L.E., Reusch J.E. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. J. Biol. Chem. 275:2000;10761-10766.
17. Kuo M.L., Chuang S.E., Lin M.T., Yang S.Y. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene. 20:2001;677-685.
18. Romashkova J.A., Makarov S.S. NF-kappaB is a target of AKT in anti- apoptotic PDGF signaling. Nature. 401:1999;86-90.
19. Pianetti S., Arsura M., Romieu-Mourez R., Coffey R.J., Sonenshein G.E. Her-2/neu overexpression induces NF-kappaB via a PI3kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene. 20:2001;1287-1299.
20. Moro L., Venturino M., Bozzo C., Silengo L., Altruda F., Beguinot L., Tarone G., Defilippi P. Integrins induce activation of EGF receptor role in MAP kinase induction and adhesion-dependent cell survival. EMBO J. 17:1998;6622-6632.
21. Walker F., Kato A., Gonez L.J., Hibbs M.L., Pouliot N., Levitzki A., Burgess A.W. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation. Mol. Cell Biol. 18:1998;7192-7204.
22. Hayakawa J., Ohmichi M., Kurachi H., Kanda Y., Hisamoto K., Nishio Y., Adachi K., Tasaka K., Kanzaki T., Murata Y. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Cancer Res. 60:2000;5988-5994.
23. Campbell S.M., Taha M.M., Medina D., Rosen J.M. A clonal derivative of mammary epithelial cell line COMMA-D retains stem cell characteristics of unique morphological and functional heterogeneity. Exp. Cell Res. 177:1988;109-121.
24. Kennedy S.G., Kandel E.S., Cross T.K., Hay N. Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell Biol. 19:1999;5800-5810.
25. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
26. Danilkovitch A., Donley S., Skeel A., Leonard E.J. Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cells. Mol. Cell Biol. 20:2000;2218-2227.
27. Widmann C., Gibson S., Johnson G.L. Caspase-dependent cleavage of signaling proteins during apoptosis a turn-off mechanism for anti-apoptotic signals. J. Biol. Chem. 273:1998;7141-7147.
28. L expression through a MEK-dependent pathway. J. Biol. Chem. 276:2001;6320-6326.
29. Mendelsohn J., Baselga J. The EGF receptor family as targets for cancer therapy. Oncogene. 19:2000;6550-6565.
30. Soares R., Pereira M.B., Silva C., Amendoeira I., Wagner R., Ferro J., Schmitt F.C. Expression of TGF-alpha and EGFR in breast cancer and its relation to angiogenesis. Breast J. 6:2000;171-177.
31. Prenzel N., Zwick E., Leserer M., Ullrich A. Tyrosine kinase signaling in breast cancer epidermal growth factor receptor: convergence point for signal integration and diversification. Breast Cancer Res. 2:2000;184-190.
32. Fabregat I., Herrera B., Fernandez M., Alvarez A.M., Sanchez A., Roncero C., Ventura J.J., Valverde A.M., Benito M. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway. Hepatology. 32:2000;528-535.
33. Gibson S., Tu S., Oyer R., Anderson S.M., Johnson G.L. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis requirement for Akt activation. J. Biol. Chem. 274:1999;17612-17618.
34. Musallam L., Ethier C., Haddad P.S., Bilodeau M. Role of EGF receptor tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 280:2001;1360-1369.
35. L. Oncogene. 16:1998;1493-1499.
36. Leverrier Y., Thomas J., Mathieu A.L., Low W., Blanquier B., Marvel J. Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ. 6:1999;290-296.
37. L promotes the open configuration of the voltage-dependent anion channel and metabolite passage through the outer mitochondrial membrane. J. Biol. Chem. 276:2001;19414-19419.
38. Vander Heiden M.G., Chandel N.S., Williamson E.K., Schumacker P.T., Thompson C.B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
39. L, and Apaf-1 form a ternary complex. J. Biol. Chem. 273:1998;5841-5845.
40. Plas D.R., Talapatra S., Edinger A.L., Rathmell J.C., Thompson C.B. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276:2001;12041-12048.
41. Juin P., Hueber A.O., Littlewood T., Evan G. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1999;1367-1381.
42. Xing C., Imagawa W. Altered MAP kinase (ERK1, 2) regulation in primary cultures of mammary tumor cells elevated basal activity and sustained response to EGF. Carcinogenesis. 20:1999;1201-1208.
43. Shakibaei M., Schulze-Tanzil G., de Souza P., John T., Rahmanzadeh M., Rahmanzadeh R., Merker H.J. Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes. J. Biol. Chem. 276:2001;13289-13294.
44. Suzuki K., Hasegawa T., Sakamoto C., Zhou Y.M., Hato F., Hino M., Tatsumi N., Kitagawa S. Cleavage of mitogen-activated protein kinases in human neutrophils undergoing apoptosis role in decreased responsiveness to inflammatory cytokines. J. Immunol. 166:2001;1185-1192.
45. Suzuki K., Takahashi K. Anchorage-independent activation of mitogen-activated protein kinase through phosphatidylinositol-3 kinase by insulin-like growth factor I. Biochem. Biophys. Res. Commun. 272:2000;111-115.
46. Sutor S.L., Vroman B.T., Armstrong E.A., Abraham R.T., Karnitz L.M. A phosphatidylinositol 3-kinase-dependent pathway that differentially regulates c-Raf and A-Raf. J. Biol. Chem. 274:1999;7002-7010.